SlimBiome® – Supporting hunger-free weight management

Slimbiome® is OptiBiotix’s patented combination of natural ingredients, identified and developed by leading experts in nutrition and metabolism, which supports scientifically substantiated weight loss claims. In independent tests the component ingredients have shown reductions in calorie intake of up to 20% along with reduced levels of cravings.

SlimBiome®’s exclusive blend of scientifically substantiated ingredients has been demonstrated to contribute to the reduction of body weight and aid the sustainability of weight loss by providing a healthy, hunger-free weight management system.

Modifying the activity of the human microbiome, the product helps accelerate weight loss while maintaining blood sugar levels helping to lessen food cravings and inducing a lower blood glucose rise after meals, compared to sugar-containing food and drinks.

Stimulating the growth of natural, beneficial bacteria in the digestive tract to affect regulation of appetite, SlimBiome® helps to create a longer-lasting feeling of fullness, while the chromium content enhances the body’s use of insulin, helping to metabolise carbohydrate and fat.

SlimBiome® Application

SlimBiome® is suitable for a wide range of functional food applications, including dairy and breaded products, snack bars and meal replacement shakes. SlimBiome® is heat stable in processing, low cost, has no distinguishable taste and can be easily added during manufacture.

Case Study

OptiBiotix has successfully launched SlimBiome® ingredients in the GoFigure® range of meal replacement shakes and natural snack bars, through its majority owned subsidiary, The Healthy Weight Loss Company. Customer feedback has shown:

  • 100% of customers who used the products over a continued period lost weight (average 1.2kg weight loss per week)
  • 100% of customers reported that using GoFigure® products led them to reduce food intake (typically by eating smaller food portions)
  • 93% of customers reported that using GoFigure products had led to reduced snacking
  • 83% of customers reported they felt less hungry when using the product
Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Optibiotix Health Plc

    More articles like this

    Optibiotix Health Plc

    NutraIngredients Awards shortlist announced

    NutraIngredients is pleased to announce the shortlisted finalists for the 2018 edition of the NutraIngredients Awards … with the winners announced at our exclusive awards evening in Geneva on 16th May. The shortlisted finalistsfor the 10

    Optibiotix Health Plc

    OptiBiotix Health plc Launch of Slimbiome® in Nutri-bites®

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, and high cholesterol, today announced the launch of its award winning SlimBiome® in Nutri-Bites® with its US partner, Cereal Ingredients (“CII”), at the 2018 Natural

    Optibiotix Health Plc

    OptiBiotix Health PLC OptiBiotix Capital Reorganisation

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek a cancellation of its share premium account (the “Capital Reduction”) in

    Optibiotix Health Plc

    Optibiotix Health PLC In a Strong Position

    Optibiotix Health PLC (LON:OPTI) Chief Executive Officer Stephen O’Hara talks to tells Proactive Investors about focussing on the commercialisation of their technology across the company’s platforms.

    Optibiotix Health Plc

    Functional weight loss ingredient, SlimBiome brought to US

    OptiBiotix Health PLC (LON:OPTI), a specialist in the development of functional ingredients to modulate the human microbiome, has entered into a manufacturing and supply agreement with Cereal Ingredients. The agreement grants Cereal Ingredients a licence to

    Optibiotix Health Plc

    OptiBiotix Health PLC Proposed Directorate Changes

    OptiBiotix Health PLC (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, today announced that subject to the completion of normal regulatory due diligence Neil Davidson CBE will be appointed as Non- Executive Chairman on 1 January 2018. Adam Reynolds, the current Non-Executive Chairman will

    Optibiotix Health Plc

    Optibiotix Health PLC on Kelloggs’ Sugar Levels Cut

    Following the announcement today from Kelloggs to cut the amount of sugar in its three top selling children’s cereals, we caught up with Stephen O’Hara, CEO of OptiBiotix Health PLC (LON:OPTI) for his thoughts:   “We are really

    Optibiotix Health Plc

    OptiBiotix Health plc will be presenting research at major USA conference

    OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced this morning that it will be presenting research data on its microbiome modulators at MicroBiome R&D and Business Collaboration (USA) in San Diego, on 2-3 November 2017. The conference is unique